particles of nanometric scale are formulated from a biodegradable polymer and a drug, a modified drug delivery/drug targeting or an improved pharmacokinetic profile of the compound is feasible. Also, improvements in selectivity, protection of the drug against fast metabolism, and more effective diffusion through biological barriers may become attainable [7].ABSTRACT The aim of this study was to formulate nanoparticles from poly(l)lactide by a modified nanoprecipitation method. The main focus was to study the effect of cosolvent selection on the shape, size, formation efficiency, degree of crystallinity, x-ray diffraction (XRD) reflection pattern, and zeta potential value of the particles. Low-molecular-weight (2000 g/mol) poly(l)lactide was used as a polymer, and sodium cromoglycate was used as a drug. Acetone, ethanol, and methanol were selected as cosolvents. Optimal nanoparticles were achieved with ethanol as a cosolvent, and the formation efficiency of the particles was also higher with ethanol as compared with acetone or methanol. The particles formulated by ethanol and acetone appeared round and smooth, while with methanol they were slightly angular. When the volume of the inner phase was decreased during the nanoprecipitation process, the mean particle size was also decreased with all the solvents, but the particles were more prone to aggregate. The XRD reflection pattern and the degree of crystallinity were more dependent on the amount of the solvents in the inner phase than on the properties of the individual cosolvents. The zeta potential values of all the particle batches were slightly negative, which partially explains the increased tendency toward particle aggregation.Nanoprecipitation has been used to formulate nanoparticles by many researchers [8][9][10]. Complex hydrodynamic processes at the interfacial area lead to the creation of the nanoparticles [8,11]. Polylactide(s) have been widely used in earlier nanoparticle studies, although the low-molecular-weight fractions of polylactic acid (PLA) have been used in few studies (L. Peltonen, P. Koistinen, J. Hirvonen, unpublished data, 2002). The interest in using low-molecular-weight PLA is based on a shorter degradation time as compared with longer chain analogues: PLA of M w 2000 g/mol, with a controlled drug release lasting for a few hours, has been shown to be suitable, for example, in pulmonary sustained-release formulations [12,13].In this article, PLA nanoparticles were formulated by a modified nanoprecipitation method. The main focus was to study the effect of selected cosolvents on the size and shape and several physicochemical properties (aggregation tendency, x-ray diffraction [XRD] pattern, zeta potential) of the particles. Sodium cromoglycate, a compound used in the treatment of bronchial asthma, was used as a model drug. Chloroform was used as a solvent for the polymer, PLA (M w = 2000 g/mol). The cosolvent (acetone, ethanol, or methanol) was used as a "poor" solvent (a driving solvent) for the polymer. The function of the cosolvent was...